Blood lipids are the primary cause of atherosclerosis, which contributes most to atherosclerotic cardiovascular disease, the leading cause of death globally.
1,2 High low-density lipoprotein cholesterol (LDL-C), the dominant form of atherogenic cholesterol, was responsible for 4.32 million deaths worldwide in 2017.
3 Triglyceride (TG) also plays an important role in cardiovascular risk through the atherogenic indicator as TG-rich lipoprotein.
1,4,5 Hence guidelines have highlighted that blood lipid control is the foundation of primary prevention of cardiovascular disease.
1,5-7 Although declining trends in blood lipid levels have occurred in Western countries over the past 2 decades,
8 the deteriorating trends persist in low- and middle-income countries due to unfavorable changes of lifestyle and environmental factors, especially in China.
9,10 Therefore, it is critical to implement effective strategies for blood lipid management among the Chinese population.